BMC Pharmacology & Toxicology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2020-07-23 太子-大医精诚

审稿速度:2.0
经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2022-04-26 12333

审稿速度:12.0 | 投稿命中率:50.0
经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵

89 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

文章题目应该包含哪些点？

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

文章题目需要注意些什么？

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2021-09-26 ms7000001737286111

审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0
偏重的研究方向：中药;肝损伤
经验分享：未投过这本期刊

115 0

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2019-09-06 xueyuan80908

两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表:
兄弟，你情况怎么样了？

187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？

131 0

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2019-09-05 121f9b9em68暂无昵称

兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表:
一个月了，还是editorial assessment，还没有送外审，太慢了吧

xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧

149 0

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2019-07-21 xueyuan80908

一个月了，还是editorial assessment，还没有送外审，太慢了吧

148 0

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2018-09-04 ms2506877623970506

审稿速度:3.0
经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。

145 0

[GetPortalCommentsPageByObjectIdResponse(id=804153, encodeId=676180415357, content=审稿速度:2.0 经验分享：快两个月了。一直显示under review，中间更新过两次时间，期待好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Thu Jul 23 16:59:26 CST 2020, time=2020-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214889, encodeId=c94c121488962, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：21年11月13号提交，12.4号才初步资格审核通过，中间非要原封不动写伦理那个话。邀请编辑，编辑邀请外审专家，外审专家接受邀请，返回意见，编辑整合意见返给我，一周后修回，等待编辑决定，两周后编辑再送外审，邀请了一周后专家接收，目前还有一个专家没返回意见给编辑，5.20 号必须要提交文章，不然就延毕了，呵呵呵呵呵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07015509193, createdName=12333, createdTime=Tue Apr 26 22:19:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105703, encodeId=bff21105e038b, content=文章题目应该包含哪些点？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105704, encodeId=22f51105e0490, content=文章题目需要注意些什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054926, encodeId=e004105492650, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:1780.0 偏重的研究方向：中药;肝损伤 经验分享：未投过这本期刊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=799f5617536, createdName=ms7000001737286111, createdTime=Sun Sep 26 10:47:09 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575953, encodeId=c6df5e5953ab, content=两个月了还是editorial assess，邮件问了，让等待，是不是bmc系列的都效率很低，看看bmc gastro评论有等一年的187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, beContent=187****7368暂无昵称 2019-09-05 00:00:00 发表: 兄弟，你情况怎么样了？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Fri Sep 06 00:00:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575850, encodeId=1d5b5e5850a9, content=兄弟，你情况怎么样了？xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=xueyuan80908 2019-07-21 00:00:00 发表: 一个月了，还是editorial assessment，还没有送外审，太慢了吧, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad032296632, createdName=121f9b9em68暂无昵称, createdTime=Thu Sep 05 00:00:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573889, encodeId=93395e3889dd, content=一个月了，还是editorial assessment，还没有送外审，太慢了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba391947785, createdName=xueyuan80908, createdTime=Sun Jul 21 00:00:00 CST 2019, time=2019-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846964, encodeId=4f78846964af, content=审稿速度:3.0 经验分享：算中等偏下的一个期刊，要不是投了几个期刊都被拒稿了，应该不会考虑这个期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb865414067, createdName=ms2506877623970506, createdTime=Tue Sep 04 15:19:10 CST 2018, time=2018-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546100, encodeId=31c25461000b, content=药理学杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d73a1995988, createdName=manjiang, createdTime=Wed Aug 30 18:02:00 CST 2017, time=2017-08-30, status=1, ipAttribution=)]

2017-08-30 manjiang

药理学杂志

294 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务